China NMPA Product Recall - ACUVUE® VITAT™ Brand Soft Contact Lenses

The National Medical Products Administration (NMPA) announced on May 18, 2021, a voluntary Class II recall initiated by Johnson & Johnson Vision Care Inc. concerning specific models and batches of its ACUVUE® VITA™ Brand Contact Lenses. This action was reported by Johnson & Johnson Vision Care Trading (Shanghai) Co., Ltd. The primary issue identified for the recall stems from certain product batches failing to meet established packaging sealing test standards. This deviation from quality specifications necessitated the recall to ensure product integrity and patient safety. Operating under the NMPA's medical device regulatory framework, this voluntary recall underscores the manufacturer's commitment to product quality and compliance. A Class II recall level indicates that the use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. As a required action, Johnson & Johnson Vision Care Inc. is actively recalling the affected ACUVUE® VITA™ Brand Contact Lenses. Further detailed information regarding the specific product models and grades involved in this recall is available within the "Medical Device Recall Event Report Form" referenced in the NMPA's announcement. This proactive measure aims to remove non-compliant products from the market and prevent potential risks to consumers.